Profile data is unavailable for this security.
About the company
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.
- Revenue in EUR (TTM)18.71bn
- Net income in EUR1.45bn
- Incorporated2000
- Employees77.75k
- LocationRoyal PhilipsAmstelplein 2AMSTERDAM 1096 BCNetherlandsNLD
- Phone+31 205977777
- Fax+31 205977220
- Websitehttps://www.philips.com/
Mergers & acquisitions
| Acquired company | PHIA:AEX since announced | Transaction value |
|---|---|---|
| Medumo Inc | 5.44% | -- |
| Carestream Health Inc-Healthcare Information Systems Business | 15.69% | -- |
| Blue Willow Systems Inc | 6.93% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Straumann Holding AG | 1.26bn | 251.39m | 11.49bn | 5.95k | 45.69 | 10.35 | 37.75 | 9.14 | 17.18 | 17.18 | 85.86 | 75.85 | 0.7657 | 2.06 | 5.05 | 229,015.80 | 15.60 | 15.83 | 18.08 | 18.33 | 74.75 | 76.72 | 20.37 | 20.79 | 2.14 | 12.72 | 0.1556 | 34.12 | 22.61 | 14.93 | -2.42 | 21.93 | 54.05 | 6.96 |
| Sartorius Stedim Biotech SA | 1.27bn | 223.25m | 12.39bn | 5.80k | 55.37 | 11.84 | 42.90 | 9.72 | 2.43 | 2.43 | 13.85 | 11.36 | 0.8173 | 2.60 | 5.56 | 225,998.20 | 14.44 | 12.47 | 19.59 | 16.59 | 51.78 | 50.89 | 17.67 | 14.71 | 0.7264 | 17.98 | 0.116 | 25.85 | 12.13 | 15.55 | 29.15 | 25.71 | 43.24 | 23.30 |
| Sonova Holding AG | 2.55bn | 418.51m | 13.49bn | 14.74k | 32.22 | 6.22 | 24.91 | 5.30 | 6.96 | 6.96 | 42.29 | 36.03 | 0.643 | 2.92 | 5.70 | 187,462.70 | 10.71 | 11.32 | 13.67 | 14.01 | 71.16 | 69.25 | 16.65 | 16.27 | 0.9997 | 81.24 | 0.2093 | 41.08 | 4.43 | 7.21 | 13.49 | 5.91 | 4.49 | 8.83 |
| Smith & Nephew plc | 4.49bn | 632.86m | 18.18bn | 16.38k | 28.76 | 4.05 | 17.39 | 4.05 | 0.6597 | 0.6597 | 4.68 | 4.68 | 0.5942 | 0.8967 | 3.98 | 250,076.00 | 8.38 | 8.62 | 10.02 | 10.47 | 73.87 | 74.21 | 14.10 | 13.38 | 0.9613 | 15.19 | 0.3056 | 45.33 | 2.92 | 2.42 | -17.02 | 3.58 | 0.4084 | 5.19 |
| Coloplast A/S | 2.30bn | 536.29m | 21.85bn | 12.00k | 43.73 | 28.33 | 35.21 | 9.48 | 18.82 | 18.82 | 80.86 | 29.05 | 1.37 | 3.17 | 5.72 | 1,485,090.00 | 31.94 | 25.63 | 62.05 | 43.18 | 67.31 | 68.14 | 23.28 | 19.28 | 0.7754 | 54.83 | 0.3027 | 103.06 | 5.93 | 7.17 | 1.26 | 7.24 | 8.74 | 9.86 |
| Siemens Healthineers AG | 14.08bn | 1.44bn | 35.35bn | 50.30k | 24.59 | 3.96 | 17.29 | 2.51 | 1.44 | 1.44 | 14.11 | 8.92 | 0.7128 | 4.12 | 4.63 | 281,600.00 | 7.35 | -- | 10.14 | -- | 40.27 | -- | 10.31 | -- | 0.9292 | 19.93 | 0.0186 | -- | -1.81 | -- | -8.27 | -- | -- | -- |
| Koninklijke Philips NV | 18.71bn | 1.45bn | 37.70bn | 77.75k | 26.77 | 3.16 | 16.46 | 2.01 | 1.56 | 1.47 | 20.10 | 13.19 | 0.7314 | 3.50 | 5.14 | 241,783.00 | 5.71 | 2.44 | 7.92 | 3.56 | 46.88 | 43.80 | 7.80 | 3.81 | 0.855 | 18.75 | 0.3278 | 114.41 | 1.92 | -3.80 | 60.07 | 4.79 | -0.3289 | 1.22 |
| EssilorLuxottica SA | 15.01bn | 1.23bn | 55.49bn | 150.62k | 39.49 | 1.65 | 18.97 | 3.70 | 3.22 | 3.22 | 42.55 | 77.25 | 0.495 | 3.53 | 6.76 | -- | 4.45 | 6.61 | 5.43 | 8.71 | 61.15 | 60.75 | 9.00 | 12.35 | 0.7337 | 20.52 | 0.1128 | 40.85 | 17.58 | 16.35 | 4.52 | 12.88 | 19.04 | 16.76 |
| Holder | Shares | % Held |
|---|---|---|
| Wellington Management Co. LLPas of 31 Dec 2018 | 65.29m | 7.21% |
| The Vanguard Group, Inc.as of 31 Jul 2019 | 32.82m | 3.63% |
| Amundi Asset Management SA (Investment Management)as of 14 Jun 2019 | 23.14m | 2.56% |
| Capital Research & Management Co. (World Investors)as of 30 Jun 2019 | 22.84m | 2.52% |
| BlackRock Investment Management LLCas of 15 Aug 2019 | 19.78m | 2.19% |
| Norges Bank Investment Managementas of 31 Dec 2018 | 17.07m | 1.89% |
| BlackRock Fund Advisorsas of 09 Aug 2019 | 12.66m | 1.40% |
| Capital Research & Management Co. (Global Investors)as of 30 Jun 2019 | 10.01m | 1.11% |
| Fidelity Management & Research Co.as of 30 Jun 2019 | 8.61m | 0.95% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 2019 | 8.57m | 0.95% |
